Skip to main content
OpenTrials
Completed

NCT Number: NCT06147492

Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer

A comprehensive study with prospectively collected data. These patients were assigned to either the taTME group or the laTME group according to the surgery procedure received

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rectal Cancer Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Male Urogenital Diseases Neoplasms Neoplasms by Site Rectal Diseases Rectal Neoplasms Urinary Retention Urination Disorders Urogenital Diseases Urologic Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Transanal total mesorectal excision has emerged as a potential solution to certain limitations associated with laparoscopic total mesorectal excision in rectal cancer patients. Differences in surgical approaches have raised questions regarding their impact on the risk of postoperative urinary retention, with limited data available from large scale study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age range from 18 to 65 years,
  • Diagnosed with rectal cancer at clinical tumor node metastasis stages II or III.
  • Palpable tumor determined by digital rectal examination or proctoscopy
  • The distal border of the tumor located within 12 cm from the anal verge

Exclusion criteria

  • Patients presenting clear indications of pelvic side wall involvement or distant metastasis
  • Uncontrolled hypertension or cardiovascular disease
  • Patients with synchronous colon cancer
  • History of other malignancies within the past 5 years

Treatment and study plan

transanal total mesorectal excision

Procedure

a transanal bottom-up approach was employed for the TME procedure

Laparoscopic Total Mesorectal Excision

Procedure

Laparoscopic Total Mesorectal Excision

Primary outcomes

  1. urinary retention

    Time frame: 30 days

    urinary retention rate

Sponsors and collaborators

Lead sponsor

Yanhong Deng

Other

Registry information

Official study title

Urinary Retention Following Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Important dates

Study start
2016
Primary completion
2020
Study completion
2023
First posted
Nov 27, 2023
Registry last updated
Nov 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.